The Biological Role of Hypothalamic Hypophysiotropic Neuropeptides

  • K. von Werder
Part of the Advances and Technical Standards in Neurosurgery book series (NEUROSURGERY, volume 14)


Four decades ago, Sir Geoffrey Harris postulated that the anterior pituitary is under hypothalamic neurohormonal control52 thus linking the brain with the endocrine system. This concept has led to a very fruitful search for the neurohormonal substances of the hypothalamus, which reach the anterior pituitary via the portal system, a vascular short cut between the neural tissue of the brain and the endocrine tissue of the pituitary113 (hypophysiotropic peptides), or which are directly secreted into the general circulation (posterior lobe peptides).


Growth Hormone Thyrotropin Release Hormone Corticotropin Release Hormone Acromegalic Patient Growth Hormone Release Hormone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abe H, Engler D, Molitch ME, Bollinger-Gruber J, Reichlin S (1985) Vasoactive intestinal peptide is a physiological mediator of prolactin release in the rat. Endocrinology 116: 1383–1390PubMedCrossRefGoogle Scholar
  2. 2.
    Arimura A, Culler MD (1985) Regulation of growth hormone secretion. In: Imura H (ed). The pituitary gland. Raven Press, New York, pp 221–259Google Scholar
  3. 3.
    Baird A, Wehrenberg WB, Bohlen P, Ling N (1985) Immunoreactive and biologically active growth hormone-releasing factor in the rat placenta. Endocrinology 117: 1508–1601CrossRefGoogle Scholar
  4. 4.
    Bauer W, Briger U, Doepfner W, Haller R, Huguenin R, Marbach P, Petcher TJ, Pless J (1982) SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31: 1133–1144PubMedCrossRefGoogle Scholar
  5. 5.
    Beck-Peccoz P, Amr, S, Menezes-Ferreira M, Faglia G, Weintraub BD (1985) Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. New Engl J Med 312: 1085–1090PubMedCrossRefGoogle Scholar
  6. 6.
    Ben-Jonathan N (1985). Dopamine: A prolactin-inhibiting hormone. Endocr Rev. 6: 564–589PubMedCrossRefGoogle Scholar
  7. 7.
    Berelowitz M, LeRoith D, von Schenk H, etal. (1982) Somatostatin like immunoreactivity and biological activity is present in Tetrahymena pyri- formis, a ciliated protozoan. Endocrinology 110: 1934–1944Google Scholar
  8. 8.
    Berg D, Rjosk HK, Jánicke F, von Werder K (1983) Behandlung der hyperprolaktinámischen Amenorrhoe durch pulsatile Gabe von Gonadotropin-Releasing Hormonen.Geburtshilfe Frauenheilkd 43: 686–688PubMedCrossRefGoogle Scholar
  9. 9.
    Berger G, Trouillas J., Bloch B, Sassolas G, Berger F, Partensky C, Chayvialle J A, Brazeau P, Claustrat B, Lesbros F, Girod C (1984) Multihormonal carcinoid tumor of the pancreas secreting growth hormone-releasing factor as a cause of acromegaly. Cancer 54: 2097–2108PubMedCrossRefGoogle Scholar
  10. 10.
    Bernutz C, Kewenig M, Horn K, Pickardt CR (1985) Detection of thyroid disorders by use of basal thyrotropin values determined with an optimized sandwich enzyme immunoassay. Clin Chem 31: 289–292PubMedGoogle Scholar
  11. 11.
    Besser GM, McNeilly AS, Anderson DC, Marshall JC, Harsoulis P, Hall R, Ormston BJ, Alexander L, Collins WP (1972) Hormonal responses to synthetic luteinizing hormone and follicle stimulating hormone-releasing hormone in man. Br Med J 3: 267–271PubMedCrossRefGoogle Scholar
  12. 12.
    Bloch B, Brazeau P, Ling N, Bohlen P, Esch F, Wehrenberg WB, Benoit R, Benoit FR, Bloom F, Guillemin R (1983) Immunohistochemical detection of growth hormone-releasing factor in brain. Nature 301: 607PubMedCrossRefGoogle Scholar
  13. 13.
    Borges JLC, Gelato MC, Rogol AD, Vance ML, MacLeod RM, Loriaux DL, Rivier J, Blizzard RM, Furlanetto R, Evans WS, Kaiser DL, Merriam GR -(1983) Effects of human pancreatic tumor growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency. Lancet 2: 119PubMedCrossRefGoogle Scholar
  14. 14.
    Borowski GD, Garofano CD, Rose LI, Lewy RA (1984) Blood pressure response to thyrotropin-releasing hormone in euthyroid subjects. J Clin Endocrinol Metab 58: 197PubMedCrossRefGoogle Scholar
  15. 15.
    Brazeau P, Vale W, Burgus R, Ling N, Rivier J, Guillemin R (1973) Hypothalamic polypeptide that inhibits the secretion of pituitary im- munoreactive growth hormone. Science 179: 77–79PubMedCrossRefGoogle Scholar
  16. 16.
    Brownstein MJ, Palkovits M, Saavedra JM, Bassiri R, Utiger RD (1974) Thyrotropin-releasing hormone in specific nuclei of rat brain. Science 185: 267–269PubMedCrossRefGoogle Scholar
  17. 17.
    Burger HG, Patel YC (1977) Thyrotropin releasing hormone - TSH. Clin Endocrinol Metab 6: 83–100PubMedCrossRefGoogle Scholar
  18. 18.
    Burgus R, Butcher M, Amoss M, Ling N, Monahan M, Rivier J, Fellows R, Blackwell R, Vale W, Guillemin R (1972) Primary structure of the hypo-thalamic luteinizing hormone-releasing factor (LRF) of ovine origin. Proc Natl Acad Sci USA 69: 278–282PubMedCrossRefGoogle Scholar
  19. 19.
    Burgus R, Dunn TF, Desiderio D, Ward DN, Vale W, Guillemin R (1970) Characterization of the hypothalamic hypophysiotropic TSH-releasing factor (TRF) of ovine origin. Nature 226: 321–325PubMedCrossRefGoogle Scholar
  20. 20.
    Carey RM, Varma SK, Drake CR, Thorner MO, Kovacs K, Rivier J, Vale W (1984) Ectopic secretion of corticotropin-releasing factor as a cause of Cushing’s syndrome. N Engl J Med 311: 13 - 20PubMedCrossRefGoogle Scholar
  21. 21.
    Charlton BG, Leake A, Ferrie IN, Linton EA, Lowry PJ (1986) Corticotropin-releasing factor in plasma of depressed patients and controls. Lancet 1: 161 - 162PubMedCrossRefGoogle Scholar
  22. 22.
    Chapman AJ, Williams G, Hockley AD, London DR (1985) Pituitary apoplexy after combined test of anterior pituitary function. Br Med J 291: 26CrossRefGoogle Scholar
  23. 23.
    Ch’ng LJC, Sandler LM, Kraenzlin ME, Burrin M, Joplin GF, Bloom SR (1985) Long term treatment of acromegaly with a long acting analogue of somatostatin. Br Med J 290: 284–285CrossRefGoogle Scholar
  24. 24.
    Chrousos GP, Schulte HM, Oldfield EH, Gold PW, Cutler GB, Loriaux DL (1984) The corticotropin-releasing factor stimulation test: An aid in the evaluation of patients with Cushing’s syndrome. N Engl J Med 310: 622–626PubMedCrossRefGoogle Scholar
  25. 25.
    Colturi TJ, Unger RH, Feldman M (1984) Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. J Clin Invest 74: 417–423PubMedCrossRefGoogle Scholar
  26. 26.
    Deuben RR, Meites J (1964) Stimulation of pituitary growth hormone release by a hypothalamic extract in vitro. Endocrinology 74: 408PubMedCrossRefGoogle Scholar
  27. 27.
    Dolva LO, Riddervold F, Thorsen RK (1983) Side effects of thyrotropin releasing hormone. Br Med J 287: 532CrossRefGoogle Scholar
  28. 28.
    Duick DS, Wahner HW (1979). Thyroid axis in patients with Cushing’s syndrome. Arch Int Med 139: 767 - 772CrossRefGoogle Scholar
  29. 29.
    Engel WK, Siddique T, Nicoloff JT (1983) Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone. Lancet 1: 73 - 75CrossRefGoogle Scholar
  30. 30.
    Evans LEJ, Hunter P, Hall R, Johnston M, Roy VM (1975) A double blind trial of intravenous thyrotropin-releasing hormone in the treatment of reactive depression. Br J Psychiatry 127: 227 - 230PubMedCrossRefGoogle Scholar
  31. 31.
    Faden AI, Jacobs TP, Holaday JW (1981) Thyrotropin-releasing hormone improves neurologic recovery after spinal trauma in cats. N Engl J Med 305: 1063 - 1067PubMedCrossRefGoogle Scholar
  32. 32.
    Faglia G, Beck-Peccoz P, Ferrari C, Ambrosi B, Spada A, Travaglini P (1973) Plasma growth hormone response to thyrotropin-releasing hormone in acromegaly. J Clin Endocrinol Metab 36: 1259–1262PubMedCrossRefGoogle Scholar
  33. 33.
    Faglia C, Bitensky L, Pinchera A, Ferrari C, Parrachi A, Beck-Peccoz P, Ambrosi B, Spada A (1979) Thyrotropin secretion in patients with central hypothyroidism: Evidence for reduced biological activity of immunoreactive thyrotropin. J Clin Endocrinol Metab 48: 989–998PubMedCrossRefGoogle Scholar
  34. 34.
    Fahlbusch R, Pickardt CR (1975) The effect of intraventricular TRH in patients with diseases of the hypothalamic and pituitary region. Acta Endocrinol 193: 90Google Scholar
  35. 35.
    Ferin M, Van Vugt D, Wardlaw S (1984) The hypothalamic control of the menstrual cycle and the role of endogenous opioid peptides. Rec Prog Horm Res 40: 441PubMedGoogle Scholar
  36. 36.
    Flückiger E, del Pozo E, von Werder K (1982). Prolactin, physiology, pharmacology and clinical findings. Monographs in Endocrinology 23, Springer, Berlin Heidelberg New YorkGoogle Scholar
  37. 37.
    Forest MG (1985) Sexual maturation of the hypothalamus: Pathophysiological aspects and clinical implications. Acta Neurochir (Wien) 75: 23–42Google Scholar
  38. 38.
    Franchimont P, Becker H, Ernould CH, Thys CH, Demoulin A, Bourguignon JP, Legros J J, Valcke JC (1974) The effect of hypothalamic luteinizing hormone releasing hormone (LHRH) on plasma gonadotropin levels in normal subjects. Clin Endocrinol 3: 27–29Google Scholar
  39. 39.
    Furutani Y, Morimoto Y, Shibahara S, etal (1983) Cloning and sequence analysis of cDNA for ovine corticotropin-releasing factor precursor. Nature 301: 537–540PubMedCrossRefGoogle Scholar
  40. 40.
    Gerich JE, Lorenzi M, Schneider V, Forsham PH (1974) Effect of somatostatin on plasma glucose and insulin responses to glucagon and tolbutamide in man. J Clin Endocrinol Metab 39: 1057–1060PubMedCrossRefGoogle Scholar
  41. 41.
    Gerich JE, Lorenzi M, Bier D, Schneider V, Tsalikia E, Karam J, Forsham PH (1975) Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon. N Engl J Med 292: 985–989PubMedCrossRefGoogle Scholar
  42. 42.
    Giguère V, Labrie F, Coté J, Coy DH, Sueiras-Diaz J, Schally AV (1982) Stimulation of cyclic AMP accumulation and adrenocorticotropin release by synthetic ovine corticotropin-releasing factor in rat anterior pituitary cells: site of glucocorticoid action. Proc Natl Acad Sci USA 79: 3466PubMedCrossRefGoogle Scholar
  43. 43.
    Gillies GE, Linton E A, Lowry PJ (1982) Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299: 355–357PubMedCrossRefGoogle Scholar
  44. 44.
    Gold PW, Goodwin FK, Wher T, Rebar R (1978) Pituitary thyrotropin response to thyrotropin-releasing hormone in affective illness: Relationship to spinal fluid amine metabolism. Am J Psychiatry 134: 1028–1031Google Scholar
  45. 45.
    Goodman RH, Jacobs JW, Dee PC, Habener JF (1982) Somatostatin-28 encoded in a cloned cDNA obtained from a rat medullary thyroid carcinoma. J Biol Chem 257: 1156–1159PubMedGoogle Scholar
  46. 46.
    Griffiths EC, Bennett GW (1983) Thyrotropin releasing hormone. Raven Press, New YorkGoogle Scholar
  47. 47.
    Gubler U, Monahan JJ, Lomedico PT, Bhatt RS, Collier KJ, Hoffman BJ, Böhlen P, Esch F, Ling N, Zeytin F, Brazeau P, Poonian MS, Gage LP (1983) Cloning and sequence analysis of cDNA for the precursor of human growth hormone-releasing factor, somtocrinin. Proc Natl Acad Sci USA 80: 4311PubMedCrossRefGoogle Scholar
  48. 48.
    Guillemin R (1978) The brain as an endocrine organ. Neurosci Res Program Bull 16: [Suppl] 1–25PubMedGoogle Scholar
  49. 49.
    Guillemin R, Brazeau P, Böhlen P, Esch F, Ling N, Wehrenberg WB (1982) Growth hormone releasing factor from a human pancreatic tumor that caused acromegaly. Science 218: 585–587PubMedCrossRefGoogle Scholar
  50. 50.
    Guillemin R, Brazeau P, Böhlen P, Esch F, Ling N, Wehrenberg WB, Bloch B, Mougin C, Zeytin F, Baird A (1984) Somatocrinin, the growth hormone releasing factor. Recent Prog Horm Res 40: 233–286PubMedGoogle Scholar
  51. 51.
    Habermann J, Leisner B, Witte A, Pickardt CR, Scriba PC (1982) Iodine contamination as a cause of hyperthyroidism or lack of TSH response to TRH stimulation (Results based on a screening investigation). J Endocrinol Invest 5: 153–156PubMedGoogle Scholar
  52. 52.
    Harris GW (1948) Neural control of the pituitary gland. Physiol Rev 28: 134–179Google Scholar
  53. 53.
    Hinkle PM, Woroch EL, Tashjian AH Jr (1974) Receptor-binding affinities and biological activities of analogs of thyrotropin-releasing hormone in prolactin-producing pituitary cells in culture. J Biol Chem 249: 3085–3090PubMedGoogle Scholar
  54. 54.
    Hofmann AR, Crowley WF (1982) Induction of puberty in men by longterm pulsatile administration of low-dose gonadotropin-releasing hormone. N Engl J Med 307: 1237–1241CrossRefGoogle Scholar
  55. 55.
    Holl R, Fehm HL, Hetzel WD, Heinze E, Voigt KH (1985) Globaler Hypophysenstimulationstest mit Releasing-Hormonen. Dtsch Med Wochenschr 110: 953–955PubMedCrossRefGoogle Scholar
  56. 56.
    Horn K, Erhardt F, Fahlbusch R, Pickardt CR, von Werder K, Scriba PC (1976) Recurrent goiter, hyperthyroidism, galactorrhea and amenorrhea due to a thyrotropin and prolactin-producing pituitary tumour. J Clin Endocrinol Metab 43: 137–143PubMedCrossRefGoogle Scholar
  57. 57.
    Imaki I, Shibasaki T, Shizume K, Masuda A, Hotta M, Kiyosawa Y, Jibiki K, Demura H, Tsushima T, Ling N (1985) The effect of free fatty acids on growth hormone (GH)-releasing hormone-mediated GH secretion in man. J Clin Endocrinol Metab 60: 290–293PubMedCrossRefGoogle Scholar
  58. 58.
    Jackson IMD (1982) Thyrotropin releasing hormone. N Engl J Med 306: 145–155PubMedCrossRefGoogle Scholar
  59. 59.
    Jackson IMD (1980) Diagnostic tests for the evaluation of pituitary tumors. In: Post KD, Jackson IMD, Reichlin S (eds). The pituitary adenoma. Plenum Press, New YorkGoogle Scholar
  60. 60.
    Jackson IMD (1978) Phylogenetic distribution and function of the hypophysi- otropic hormones of the hypothalamus. Am Zoologist 18: 385–399CrossRefGoogle Scholar
  61. 61.
    Jackson IMD, Reichlin S (1974) Thyrotropin releasing hormone (TRH): Distribution in the brain, blood and urine of the rat. Life Sci 14: 2253–2266CrossRefGoogle Scholar
  62. 62.
    Jacobs LS, Snyder PJ, Utiger RD, Daughaday WH (1973) Prolactin response to thyrotropin releasing hormone in normal subjects. J Clin Endocrinol Metab 36: 1069–1073PubMedCrossRefGoogle Scholar
  63. 63.
    Kastin AJ, Ehrensing RH, Schalch DS, Anderson MS (1972) Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone. Lancet 2: 740–742PubMedCrossRefGoogle Scholar
  64. 64.
    Knobil E (1980) The neuroendocrine control of the menstrual cycle. Recent Prog Horm Res 36: 53–88PubMedGoogle Scholar
  65. 65.
    Knobil E, Plant TM, Wildt L, Blecher PE, Marshall G (1980) Control of the rhesus monkey menstrual cycle: permissive role of the hypothalamic gonadotrophin-releasing hormone. Science 207: 1371PubMedGoogle Scholar
  66. 66.
    Kourides IA, Ridgway EC, Weintraub BC, Bigos ST, Gershengorn MC, Maloof F (1977) Thyrotropin-induced hyperthyroidism: Use of alpha and beta subunit levels to identify patients with pituitary tumours. J Clin Endocrinol Metab 45: 534–543PubMedCrossRefGoogle Scholar
  67. 67.
    Krejs GJ, Orci L, Conlon JM, Ravazzola M, Davis GR, Raskin P, Collins SM, McCarthy DM, Baetens D, Rubenstein A, Aldor AM, Unger RH (1979) Somatostatinoma syndrome. Biochemical, morphological and clinical features. N Engl J Med 301: 285–292PubMedCrossRefGoogle Scholar
  68. 68.
    Krieger DT, Condon EM (1978) Cyproheptadine treatment of Nelson’s syndrome: restoration of plasma ACTH circadian periodicity and reversal of response of TRF. J Clin Endocrinol Metab 46: 349–352PubMedCrossRefGoogle Scholar
  69. 69.
    Krieger DT (1983) Physiopathology of Cushing’s disease. Endocr Rev 4: 22PubMedCrossRefGoogle Scholar
  70. 70.
    Krulich L, Dhariwal APS, McCann SM (1968) Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology 83: 783–790PubMedCrossRefGoogle Scholar
  71. 71.
    Labrie F, Dupont A, Belanger A (1984) Spectacular response to combined antihormonal treatment in advanced prostate cancer. In: Labrie F, Proulx L (eds) Endocrinology. Excerpta Medica, Amsterdam New York Oxford, pp 450–453Google Scholar
  72. 72.
    Labrie F, Veilleux R, Lefevre G, Coy DH, Sueiras-Diaz J, Schally AV (1982) Corticotropin-releasing factor stimulates accumulation of adenosine 3′,5′- monophosphate in rat pituitary corticotrophs. Science 216: 1007PubMedCrossRefGoogle Scholar
  73. 73.
    Lamberts SWJ, Uitterlinden P, Verschoor L, van Dongen KJ, Del Pozo E (1985) Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995. N Engl J Med 313: 1576–1580PubMedCrossRefGoogle Scholar
  74. 74.
    Lamberts SWJ, Verleun T, Oosterom R, DeJong F, Hackens WHL (1984) Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man. J Clin Endocrinol Metab 58: 298–303PubMedCrossRefGoogle Scholar
  75. 75.
    Lance VA, Murphy WA, Sueiras-Diaz J, Coy EH (1984) Superactive analogs of growth hormone releasing factor (l-29)-amide. Biochem Biophys Res Commun 119: 265PubMedCrossRefGoogle Scholar
  76. 76.
    Laron Z, Keret R, Bauman B, Pertzelan A, Ben-Zeev Z, Olsen DB, Comaru- Schally AM, Schally AV (1984) Differential diagnosis between hypothalamic and pituitary hGH deficiency with the aid of synthetic GH-RH 1–44. Clin Endocrinol 21: 9CrossRefGoogle Scholar
  77. 77.
    Leitner JW, Rifkin RM, Maman A, Sussman KE (1979) Somatostatin binding to pituitary plasma membranes. Biochem Biophys Res Commun 87: 919–927PubMedCrossRefGoogle Scholar
  78. 78.
    Leyendecker G, Wildt L (1983) Induction of ovulation with chronic- intermittent (pulsatile) administration of GnRH in hypothalamic amenorrhea. J Reprod Fertil 69: 397PubMedCrossRefGoogle Scholar
  79. 79.
    Leyendecker G, Wildt L, Hansmann M (1980) Pregnancies following chronic intermittent (pulsatile) administration of GnRH by means of portable pump (Zyklomat)—a new approach to the treatment of infertility in hypothalamic amenorrhea. J Clin Endocrinol Metab 51: 1214–1216PubMedCrossRefGoogle Scholar
  80. 80.
    Lightman S, Unwin RJ, Graham K, Dimaline R, Mc Garrick G (1984) Vasoactive intestinal polypeptide stimulation of prolactin release and renin activity in normal man and patients with hyperprolactinemia. Effects of pretreatment with bromocriptine and dexamethasone. Eur J Clin Invest 14: 444–448PubMedCrossRefGoogle Scholar
  81. 81.
    Linde R, Doelle GC, Alexander N, Kirchner F, Vale W, Rivier J, Rabin D (1981) Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men. N Engl J Med 305: 663–667PubMedCrossRefGoogle Scholar
  82. 82.
    Ling N, Esch F, Bohlen P, Brazeau P, Wehrenberg WB, Guillemin R (1984) Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. Proc Natl Acad Sci USA 81: 4302–4306PubMedCrossRefGoogle Scholar
  83. 83.
    Ling N, Zeytin F, Bohlen P, Esch F, Brazeau P, Wehrenberg WB, Baird A, Guillemin R (1985) Growth hormone releasing factor. Ann Rev Biochem 54: 403–423PubMedCrossRefGoogle Scholar
  84. 84.
    Liuzzi A, Chiodini PG, Botalla L, Silvestrini F, Muller EE (1974) Growth hormone (GH)-releasing activity of TRH and GH lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses. J Clin Endocrinol Metab 39: 871–874PubMedCrossRefGoogle Scholar
  85. 85.
    Losa M, Bock L, Schopohl J, Stalla GK, Müller OA, von Werder K (1984) Growth hormone releasing factor infusion does not sustain elevated GH- levels in normal subjects. Acta Endocrinol 107: 462–470PubMedGoogle Scholar
  86. 86.
    Losa M, Müller OA, Sobieszczyk, von Werder K (1985) Interaction between growth hormone releasing factor (GRF) and somatostatin analogue (SMS 201-995) in normal subjects. Clin Endocrinol 23: 715–720CrossRefGoogle Scholar
  87. 87.
    Losa M, Schopohl J, Stalla GK, Müller OA, von Werder K (1985) Growth hormone releasing factor-test in acromegaly: Comparison with other dynamic tests. Clin Endocrinol 23: 99–109CrossRefGoogle Scholar
  88. 88.
    Losa M, Schopohl J, Müller OA, von Werder K (1984) Stimulation of growth hormone secretion with human growth hormone releasing factors (GRF 1- 44, GRF 1-40, GRF 1-29) in normal subjects. Klin Wochenschr 62: 1140–1143PubMedCrossRefGoogle Scholar
  89. 89.
    Losa M, Stalla GK, Müller OA, von Werder K (1983) Human pancreatic growth hormone releasing factor (hpGRF): Dose response of GRF- and GH- levels. Klin Wochenschr 61: 1249–1253PubMedCrossRefGoogle Scholar
  90. 90.
    Mansfield MJ, Beardsworth DE, Loughlin JS, Crawford JD, Bode HH, Rivier J, Vale W, Kushner DV, Crigler JF, Crowley WF (1983) Long-term treatment of central precocious puberty with longacting analogue of luteiniz¬ing hormone-releasing hormone. N Engl J Med 109: 1286–1290CrossRefGoogle Scholar
  91. 91.
    Masuda A, Shibasaki T, Nakahara M, Imahi T, Kiyosawa Y, Jikibi K, Demura H, Shizume K, Ling N (1985) The effect of glucose on growth hormone (GH)-releasing hormone-mediated GH-secretion in man. J Clin Endocrinol Metab 60: 523–526PubMedCrossRefGoogle Scholar
  92. 92.
    Matsuo H, Baba Y, Nair RMG, Arimura A, Schally AV (1971) Structure of the porcine LH- and FSH-releasing hormone. I. Proposed amino acid sequence. Biochem Biophys Res Commun 43: 1374–1439CrossRefGoogle Scholar
  93. 93.
    McCann SM (1983) Progress in neuroendocrinology: LH releasing (LHRH), basic and clinical aspects. J Endocrinol Invest 6: 24–251Google Scholar
  94. 94.
    McCann SM, Krulich L, Negro-Vilar A, Ojeda SR, Vijayan E (1980) Regulation and function of panhibin (somatostatin). Adv Biochem Psycho- pharmacol 22: 131–143Google Scholar
  95. 95.
    McCann SM (1971) Mechanism of action of hypothalamic hypophyseal stimulating and inhibiting hormones. In: Ganong WF, Martini L (eds) Frontiers in neuroendocrinology. Oxford University Press, New York, p 209Google Scholar
  96. 96.
    Melmed S, Braunstein GD, Horvath E, Ezrin C, Kovacs K (1983) Pa-thophysiology of acromegaly. Endocr Rev 4: 271PubMedCrossRefGoogle Scholar
  97. 97.
    Melmed S, Ezrin C, Kovacs K, Goodman RS, Frohman LA (1985) Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor. N Engl J Med 312: 9PubMedCrossRefGoogle Scholar
  98. 98.
    Metcalf G, Dettmar PW (1981) Is thyrotropin-releasing hormone an endo-genous ergotropic substance in the brain? Lancet 1: 586–589PubMedCrossRefGoogle Scholar
  99. 99.
    Morley JE (1981) Neuroendocrine control of thyrotropin secretion. Endocr Rev 2: 396PubMedCrossRefGoogle Scholar
  100. 100.
    Morris DV, Adeniyi-Jones R, Wheeler M, Sonksen P, Jacobs HS (1984) The treatment of hypogonadotrophic hypogonadism in men by the pulsatile infusion of luteinizing hormone-releasing hormone. Clin Endocrinol 21: 189–200CrossRefGoogle Scholar
  101. 101.
    Moss RL, McCann SM (1973) Induction of mating behavior in rats by luteinizing hormone releasing factor. Science 181: 177PubMedCrossRefGoogle Scholar
  102. 102.
    Müller OA, Dörr HG, Hagen B, Stalla GK, von Werder K (1982) Corticotropin releasing factor (CRF)-stimulation test in normal controls and patients with disturbances of the hypothalamo pituitary-adrenal axis. Klin Wochenschr 60: 1485–1491PubMedCrossRefGoogle Scholar
  103. 103.
    Müller OA, Stalla GK, Hartwimmer J, Schopohl J, von Werder K (1985) Corticotropin releasing factor (CRF): Diagnostic implications. Acta Neurochir (Wien) 75: 49–59CrossRefGoogle Scholar
  104. 104.
    Müller OA, Stalla GK, von Werder K (1983) Corticotropin releasing factor: A new tool for the differential diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 57: 227–229PubMedCrossRefGoogle Scholar
  105. 105.
    Nahagawa K, Akikawa K, Matsubara M, Kubo M (1985) Effect of dexamethasone on growth hormone (GH) response to growth hormone releasing hormone in acromegaly. J Clin Endocrinol Metab 60: 306–310CrossRefGoogle Scholar
  106. 106.
    Naor Z, Catt KJ (1980) Independent actions of gonadotropin releasing hormone upon cyclic GMP production and LH release. J Biochem 225: 342Google Scholar
  107. 107.
    Nikolics K, Mason AJ, Szönyi E, Ramachandran J, Seeburg PH (1985) A prolactin-inhibiting factor within the precursor for human gonadotropin- releasing hormone. Nature 316: 511PubMedCrossRefGoogle Scholar
  108. 108.
    Nillius SJ, Bergquist C, Wide L (1978) Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue—a new approach to birth control? Contraception 17: 537–544CrossRefGoogle Scholar
  109. 109.
    Odell WD, Swerdloff RS (1978) Abnormalities of gonadal function in men. Clin Endocrinol 8: 149–180CrossRefGoogle Scholar
  110. 110.
    Orci L, Baetens D, Dubois MP, Rufener C (1975) Evidence for the D-cell of the pancreas secreting somatostatin. Horm Metab Res 7: 400–402PubMedCrossRefGoogle Scholar
  111. 111.
    Orth DN (1984) The old and the new in Cushing’s syndrome. N Engl J Med 310: 649–651PubMedCrossRefGoogle Scholar
  112. 112.
    Orth DN, Jackson RY, DeCherney GS, DeBold CR, Alexander AN, Island DP, Rivier J (1983) Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and Cortisol. J Clin Invest 71: 587–595PubMedCrossRefGoogle Scholar
  113. 113.
    Page RB (1982) Pituitary blood flow. Am J Physiol 243 (Endocrinol Metab 6) E427–E442PubMedGoogle Scholar
  114. 114.
    Pandol SJ, Seifert H, Thomas MW, Rivier J, Vale W (1984) Growth hormone releasing factor stimulates pancreatic enzym secretion. Science 225: 326–328PubMedCrossRefGoogle Scholar
  115. 115.
    Patel YC, Rao K, Reichlin S (1977) Somatostatin in human cerebrospinal fluid. N Engl J Med 296: 529–533PubMedCrossRefGoogle Scholar
  116. 116.
    Pelletier G (1980) Immunohistochemical localization of somatostatin. Prog Histochem Cytochem 12 (3): 1–41PubMedGoogle Scholar
  117. 117.
    Penny ES, Penman E, Price J, Rees LH, Sopwith AM, Wass JAH, Lytras N, Besser GM (1984) Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly. Br Med J 289: 453CrossRefGoogle Scholar
  118. 118.
    Philips HS, Hostetter G, Kerdelhue B, Kozlowski GB (1980) Immunocyto- chemical localization of LHRH in central olfactory pathways of hamster. Brain Res 193: 574CrossRefGoogle Scholar
  119. 119.
    Pickardt CR, Scriba PC. TRH (1985) Pathophysiologic and clinical implications. Acta Neurochir (Wien) 75: 43–48CrossRefGoogle Scholar
  120. 120.
    Pieters GFFM, Hermus ARMM, Smais AGH, Bertelink AKM, Benraad THJ, Kloppenborg PWC (1983) Responsiveness of the hypophyseal- adrenocortical axis to corticotropin releasing factor in pituitary-dependent Cushing’s disease. J Clin Endocrinol Metab 57: 513–516PubMedCrossRefGoogle Scholar
  121. 121.
    Plewe G, Beyer J, Krause U, Neufeld M, Del Pozo E (1984) Long acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201-995 in acromegaly. Lancet 2: 782–784PubMedCrossRefGoogle Scholar
  122. 122.
    Polak JM, Pearse AGE, Grimelius L, Bloom SR, Arimura A (1975) Growth- hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet 5: 1220–1222CrossRefGoogle Scholar
  123. 123.
    Proulx L, Giguere V, Coté J, Labrie F (1984) Multiple factors involved in the control of ACTH secretion. J Endocrinol Invest 7: 257–263PubMedGoogle Scholar
  124. 124.
    Raptis S, Rosenthal J, Gerich JE (eds) (1974) Proceedings of the 2nd International Symposium on somatostatin. Attempto, Tübingen University Press, Tübingen, FRGGoogle Scholar
  125. 125.
    Reichlin S (1985) Neuroendocrinology, In: Williams textbook of endocrinology, 7th ed, Saunders WB, Philadelphia, pp 492–567Google Scholar
  126. 126.
    Reichlin S (1983) Somatostatin. N Engl J Med 309: 1495-1501, 1556–1563PubMedCrossRefGoogle Scholar
  127. 127.
    Reichlin S (1960). Growth and the hypothalamus. Endocrinology 67: 760CrossRefGoogle Scholar
  128. 128.
    Reichlin S, Martin JB, Jackson IMD (1978). Regulation of thyroid- stimulating hormone (TSH) secretion. In: Jeffcoate SL, Hutchinson JSM (eds). The endocrine hypothalamus. Academic Press, New YorkGoogle Scholar
  129. 129.
    Reid IA, Rose JC (1977) An intrarenal effect of somatostatin on water excretion. Endocrinology 100: 782–785PubMedCrossRefGoogle Scholar
  130. 130.
    Richter D, Ivell R (1985) Gene organization, biosynthesis, and chemistry of neurohypophyseal hormones. In: Imura H (ed). The pituitary gland. Raven Press, New York, pp 127–148Google Scholar
  131. 131.
    Rivier J, Rivier C, Vale W (1984) Synthetic competitive antagonists of corticotropin-releasing factor: Effect on ACTH secretion in the rat. Science 224: 889–891PubMedCrossRefGoogle Scholar
  132. 132.
    Rivier C, Vale W (1983) Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 113: 939PubMedCrossRefGoogle Scholar
  133. 133.
    Rjosk HK, von Werder K, Fahlbusch R (1976) Hyperprolaktinämische Amenorrhoe. Geburtshilfe Frauenheilkd 36: 575–587PubMedGoogle Scholar
  134. 134.
    Robert JF, Quigley ME, Yen SSC (1981) Endogenous opiates modulate pulsatile luteinizing hormone release in humans. J Clin Endocrinol Metab 52: 583 - 585CrossRefGoogle Scholar
  135. 135.
    Root AW, Snyder PJ, Rezvani I, DiGeorge AM, Utiger RD (1973) Inhibition of thyrotropin-releasing hormone-mediated secretion of thyrotropin by human growth hormone. J Clin Endocrinol Metab 36: 103–107PubMedCrossRefGoogle Scholar
  136. 136.
    Rossor MN, Emson PC, Mountjoy CQ, Roth M, Iversen LL (1980) Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type. Neurosci Lett 20: 373–377PubMedCrossRefGoogle Scholar
  137. 137.
    Saito H, Saito S, Yamazaki R, Hoso E (1984) Clinical value of radioimmunoassay of plasma growth hormone-releasing factor. Lancet 2: 401PubMedCrossRefGoogle Scholar
  138. 138.
    Samson WK, McCann SM, Chud L, Dudley CA, Moss RL (1980) Intra and extrahypothalamic luteinizing hormone releasing hormone distribution in the rat with special reference to mesencephalic sites which contain both LHRH and single neurons responsive to LHRH. Neuroendocrinology 31: 66PubMedCrossRefGoogle Scholar
  139. 139.
    Sandow J (1983) Clinical applications of LHRH and its analogues. Clin Endocrinol 18: 571 - 592CrossRefGoogle Scholar
  140. 140.
    Scanlon MF, Weightman DR, Shale DJ, More B, Heath M, Snow MH, Lewis M, Hall R (1979) Dopamine is a physiological regulator of thyrotropin (TSH) secretion in normal man. Clin Endocrinol 10: 7–15CrossRefGoogle Scholar
  141. 141.
    Scheithauer BW, Carpenter PC, Bloch B, Brazeau P (1984) Ectopic secretion of a growth hormone releasing factor. Am J Med 76: 605–616PubMedCrossRefGoogle Scholar
  142. 142.
    Schopohl J, Losa M, König A, Müller OA, Stalla GK, von Werder K (1986) Combined pituitary function test with four hypohalamic releasing hormones. Klin Wochenschr 64: 314–318PubMedCrossRefGoogle Scholar
  143. 143.
    Schürmeyer TH, Knuth UA, Freischem CW, Sandow J, Bint Akhtar F, Nieschlag E (1984) Suppression of pituitary and testicular function in normal men by constant gonadotropin-releasing hormone agonist infusion. J Clin Endocrinol Metab 59: 19–24PubMedCrossRefGoogle Scholar
  144. 144.
    Schulte EH, Loriaux DL (1983) Safety of corticotropin-releasing factor. Lancet 1: 1222PubMedCrossRefGoogle Scholar
  145. 145.
    Schusdziarra V, Rouillar D, Unger RH (1979) Oral administration of somatostatin reduces postprandial plasma triglycerides, gastrin and gut glucagon-like immunoreactivity. Life Sci 24: 1595–1600PubMedCrossRefGoogle Scholar
  146. 146.
    Schusdziarra V, Zyznar E, Rouiller D, etal (1980) Splanchnic somatostatin: a hormonal regulator of nutrient homeostasis. Science 207: 530–532PubMedCrossRefGoogle Scholar
  147. 147.
    Selye H (1936) A syndrome produced by diverse noxious agents. Nature 138: 32CrossRefGoogle Scholar
  148. 148.
    Sharp PS, Foley K, Chadal P, Kohner EM (1984) The effect of plasma glucose on the growth hormone response to human pancreatic growth hormone releasing factor in normal subjects. Clin Endocrinol 20: 497 - 501CrossRefGoogle Scholar
  149. 149.
    Sheldon H (1985) Growth hormone and prolactin: Chemistry, gene organization, biosynthesis, and regulation of gene expression. In: Imura H (ed). The pituitary gland. Raven Press, New York, pp 57–82Google Scholar
  150. 150.
    Shen LP, Pictet RL, Rutter WJ (1982) Human somatostatin I: sequence of the cDNA. Proc Natl Acad Sei USA 79: 4575–4579CrossRefGoogle Scholar
  151. 151.
    Shibahara S, Morimoto Y, Furutani Y, etal (1983) Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene. EMBO J 2: 775–779PubMedGoogle Scholar
  152. 152.
    Shibasaki T, Hotta M, Masuda A, Imaki T, Obara N, Demura H, Ling N, Shizume K (1985) Plasma GH responses to GRH and insulin induced hypoglycemia in man. J Clin Endocrinol Metab 60: 1265–1267PubMedCrossRefGoogle Scholar
  153. 153.
    Shibasaki T, Hotta M, Masuda A, Imaki T, Obara N, Demura H, Ling N, Shizume K (1985) Plasma GH responses to GRH and insulin induced hypoglycemia in man. J Clin Endocrinol Metab 60: 1265–1267PubMedCrossRefGoogle Scholar
  154. 154.
    Shibasaki T, Kiyosawa Y, Masuda A, Nakahara M, Imaki T, Wakabayashi I, Demura H, Shizume K, Ling N (1984) Distribution of growth hormone releasing hormone-like immunoreactivity in human tissue extracts. J Clin Endocrinol Metab 59: 263–268PubMedCrossRefGoogle Scholar
  155. 155.
    Shields D, Warren TG, Green RF, Roth SE, Brenner MJ (1981) The primary events in the biosynthesis and post-translational processing of different precursors to somatostatin. In: Rich DH, Cross E (eds). Peptides: Synthesis- structure-function: Proceedings of the seventh American Peptide Symposium. Pierce Chemical Company, Rockford, 111, pp 471–479Google Scholar
  156. 156.
    Siler-Khodr TM (1983) Hypothalamic-like peptides of the placenta. Seminars in Reprod Endocrin 1: 321–333CrossRefGoogle Scholar
  157. 157.
    Snyder PJ, Jacobs LS, Rabello MM, Sterling FH, Shore RN, Utiger RD, Daughaday WH (1974) Diagnostic value of thyrotropin-releasing hormone in pituitary and hypothalamic diseases: Assessment of thyrotropin and pro¬lactin secretion in 100 patients. Ann Intern Med 81: 751 - 757PubMedGoogle Scholar
  158. 158.
    Snyder PJ, Jacobs LS, Utiger RD, Daughaday WH (1973) Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone. J Clin Invest 52: 2324–2329PubMedCrossRefGoogle Scholar
  159. 159.
    Snyder G, Naor Z, Fawcett CP, McCann SM (1980) Gonadotropin release and cyclic nucleotides: evidence for LHRH-induced elevation of cyclic GMP levels in gonadotrophs. Endocrinology 107: 1627PubMedCrossRefGoogle Scholar
  160. 160.
    Snyder PJ, Utiger RD (1972) Response to thyrotropin releasing hormone (TRH) in normal man. J Clin Endocrinol Metab 34: 380–385PubMedCrossRefGoogle Scholar
  161. 161.
    Sopwith AM, Penny ES, Besser GM, Rees LH (1985) Stimulation by food of peripheral plasma immunoreactive growth hormone releasing factor. Clin Endocrinol 22: 337–340CrossRefGoogle Scholar
  162. 162.
    Stalla GK, Hartwimmer J, Kaliebe T, Müller OA (1985) Radioimmunoassay of human corticotropin releasing factor (hCRF). Acta Endocr (Kbh) Suppl. 108: 18–19Google Scholar
  163. 163.
    Stalla GK, Hartwimmer J, von Werder K, Müller OA (1984) Ovine (o) and human (h) corticotropin releasing factor (CRF) in man: CRF-stimulation and CRF-immunoreactivity. Acta Endocrinol 106: 289–297PubMedGoogle Scholar
  164. 164.
    Suda T, Tomori N, Yajima F, Sumitomo T, Nakagami Y, Ushiyama T, Demura H, Shizume K (1985) Immunoreactive corticotropin-releasing factor in human plasma. J Clin Invest 76: 2026–2029PubMedCrossRefGoogle Scholar
  165. 165.
    Takahashi JS, Zatz M (1982) Regulation of circadian rhythmicity. Science 217: 1104–1111PubMedCrossRefGoogle Scholar
  166. 166.
    Tanjasiri P, Kozbur X, Florsheim WH (1976) Somatostatin in the physiologic feedback control of thyrotropin secretion. Life Sci 19: 657–660PubMedCrossRefGoogle Scholar
  167. 167.
    Thorner MO, Frohman LA, Leong DA, Thominet J, Downs T, Hellman P, Chitwood J, Vaughan JM, Vale W, Besser GM, Lytras N, Edwards CRV, Schaff M, Gelato M, Krieger DT, Marcovitz S, Ituarte E, Boyd AE, Malarkey WB, Blackard WG, Prioleau G, Melmed S, Charest NJ (1984) Extrahypothalamic growth-hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients. J Clin Endocrinol Metab 59: 846–849PubMedCrossRefGoogle Scholar
  168. 168.
    Thorner MO, Perryman RL, Cronin MJ, Rogol AD, Draznin M, Johanson A, Yale W, Horvath E, Kovacs K (1982) Somatotroph hyperplasia: successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. J Clin Invest 70: 965–977PubMedCrossRefGoogle Scholar
  169. 169.
    Thorner MO, Reschke J, Chitwood J, Rogol AD, Furlanetto R, Rivier J, Vale W, Blizzard RM (1985) Acceleration of growth in two children treated with human growth hormone-releasing factor. N Engl J Med 312: 4–9PubMedCrossRefGoogle Scholar
  170. 170.
    Thorner MO, Spiess J, Vance ML, Rogol AD, Kaiser DL, Webster JD, Rivier J, Borges JL, Bloom SR, Cronin MJ, Evans WS, Mac Leod RM, Vale W (1983) Human pancreatic growth hormone releasing factor selectively stimulates growth hormone secretion in man. Lancet 1: 24–28PubMedCrossRefGoogle Scholar
  171. 171.
    Usadel KH, Leuschner U, Überla KK (1980) Treatment of acute pancreatitis with somatostatin: a multicenter double-blind trial. N Engl J Med 303: 999–1000PubMedCrossRefGoogle Scholar
  172. 172.
    Vale W, Rivier C, Brown MR, Spiess J, Koob G, Swanson L, Bilezikjian L, Bloom F, Rivier J (1983) Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res 39: 245–270PubMedGoogle Scholar
  173. 173.
    Vale W, Spiess J, Rivier C, Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and ß- endorphine. Science 213: 1394–1397PubMedCrossRefGoogle Scholar
  174. 174.
    Vale W, Vaughan J, Yamamoto G, Spiess J, Rivier J (1983) Effects of synthetic human pancreatic (tumor) GH releasing factor and somatostatin, triiodothy-ronine and dexamethasone on GH-secretion in vitro. Endocrinology 112: 1553–1555PubMedCrossRefGoogle Scholar
  175. 175.
    Van Cauter E, Refetoff S (1985) Evidence for two subtypes of Cushing’s disease based on the analysis of episodic Cortisol secretion. N Engl J Med 312: 1343–1349PubMedCrossRefGoogle Scholar
  176. 176.
    Vance ML, Kaiser DL, Evans WS, Furlanetto R, Vale W, Rivier J, Thorner MO (1985) Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1- 40). J Clin Invest 75: 1584–1590PubMedCrossRefGoogle Scholar
  177. 177.
    Van Loon GR, Brown GM (1975) Secondary drug failure occurring during chronic treatment with LHRH: appearance of an antibody. J Clin Endocrinol Metab 41: 640–643PubMedCrossRefGoogle Scholar
  178. 178.
    Veldhuis JD, Rogol AD, Johanson ML, Dufau ML (1983) EndogenousGoogle Scholar
  179. 179.
    Webb CB, Vance ML, Thorner MO, Perisutti G, Thominet J, Rivier J, Vale W, Frohman LA (1985) Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. J Clin Invest 74: 96–103CrossRefGoogle Scholar
  180. 180.
    Waxman J (1984) Analogues of gonadotropin releasing hormone. Br Med J 288: 426–237CrossRefGoogle Scholar
  181. 181.
    Webb CB, Vance ML, Thorner MO, Perisutti G, Thominet J, Rivier J, Vale W, Frohman LA (1985) Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. J Clin Invest 74: 96–103CrossRefGoogle Scholar
  182. 182.
    Weiner RI, Elias KA, Monnet F (1985) The role of vascular changes in the etiology of prolactin secreting anterior pituitary tumors. In: Mac Leod RM, Thorner MO, Scapagnini U (eds). Prolactin. Basic and clinical correlates. Fidia Research Series, Liviana Press, Padova, pp 641–653Google Scholar
  183. 183.
    Weiner RI, Ganong WF (1978) Role of brain monoamines and histamine in regulation of anterior pituitary secretion. Physiol Rev 58: 905–976PubMedGoogle Scholar
  184. 184.
    Weissei M, Stummvoll HK, Kolbe H, Höfer R (1979) Basal and TRH- stimulated thyroid and pituitary hormones in various degrees of renal insufficiency. Acta Endocrinol 909: 23–32Google Scholar
  185. 185.
    Wenzel KW (1981) Pharmacological interference with in vitro tests of thyroid function. Metabolism 30: 717–732PubMedCrossRefGoogle Scholar
  186. 186.
    Wenzel KW (1981) Pharmacological interference with in vitro tests of thyroid function. Metabolism 30: 717–732PubMedCrossRefGoogle Scholar
  187. 187.
    von Werder K (1985) Recent advances in the diagnosis and treatment of hyperprolactinemia. In: Imura H (ed) The pituitary gland. Raven Press, New York, pp 405–439Google Scholar
  188. 188.
    von Werder K, Fahlbusch R (1978) GnRH and TRH stimulated GH secretion in active and inactive acromegaly. In: Voelter W, Gupta D (eds) Hypo¬thalamic hormones. Verlag Chemie, New York Weinheim, pp 677–683Google Scholar
  189. 189.
    von Werder K, Losa M, Müller OA, Schweiberer L, Fahlbusch R, Del Pozo E (1984) Treatment of metastasising GRF-producing tumour with a long- acting somatostatin analogue. Lancet 2: 282–283CrossRefGoogle Scholar
  190. 190.
    von Werder K, Müller OA (1975) Medical therapy of hypothalamic diseases. Acta Neurochir (Wien) 75: 147–151CrossRefGoogle Scholar
  191. 191.
    von Werder K, Müller OA (1985) Corticotropin- and growth hormone releasing factor (CRF and GRF) in the diagnosis of hypothalamo-pituitary diseases. Neurosurg Rev 8: 155–165CrossRefGoogle Scholar
  192. 192.
    von Werder K, Müller OA, Hard R, Losa M, Stalla GK (1984) Growth hormone releasing factor (hpGRF)-stimulation test in normal controls and acromegalic patients. J Endocrinol Invest 7: 185–191Google Scholar
  193. 193.
    de Wied D (1982) Neuropeptides and psychopathology. Eur J Clin Invest 12: 281 - 284PubMedCrossRefGoogle Scholar
  194. 194.
    Williams I, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W, Frohman LA (1984) Impaired growth hormone responses to growth hormone releasing factor in obesity. N Engl J Med 311: 1403–1407PubMedCrossRefGoogle Scholar
  195. 195.
    Zingg HH, Patel YC (1982) Biosynthesis of immunoreactive somatostatin by hypothalamic neurons in culture. J Clin Invest 70: 1101–1109PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1986

Authors and Affiliations

  • K. von Werder
    • 1
  1. 1.Medizinische Klinik InnenstadtUniversity of MunichMunichFederal Republic of Germany

Personalised recommendations